Acessibilidade / Reportar erro

Blood Pressure Variability and Cardiovascular Risk in ELSA-Brasil: A Potential Surrogate Marker for Predicting Mortality and Cardiovascular Outcomes?

Blood Pressure; Homeostasis; Cardiovascular Diseases; Risk Factors; Hypertension

Blood pressure (BP) homeostasis is a crucial element in the protection of cardiovascular events. Many national and international guidelines11. Barroso WKS, Rodrigues CIS, Bortolotto LA, Mota-Gomes MA, Brandão AA, Feitosa ADM, et al. Diretrizes Brasileiras de Hipertensão Arterial – 2020. Arq Bras Cardiol. 2021; 116(3):516-658.doi: 10.36660/abc.20201238.
https://doi.org/10.36660/abc.20201238...

2. Précoma DB, Oliveira GMM, Simão AF, Dutra OP, Coelho OR, Izar MCO, et al. Atualização da Diretriz de Prevenção Cardiovascular da Sociedade Brasileira de Cardiologia – 2019. Arq Bras Cardiol. 2019; 113(4):787-891. doi: 10.5935/abc.20190204.

3. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bach M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur J Prev Cardiol.2022;29(1):5-115 doi:10.1093/eurjpc/zwab154.
- 44. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension 2020;75(6):1334-57. doi: 10.1161/HYPERTENSIONAHA.120.15026. have proposed target values for blood pressure, and these recommendations consider slightly different goals according to hypertension stages, risk stratification and presence of renal or cardiovascular diseases, and target organ lesion. However, these values are based on office measures, ambulatory blood pressure monitoring (ABPM) and home blood pressure monitoring (HBPM), not accounting for blood pressure variability (BPV). BP intraindividual variability is an independent risk factor for cardiovascular diseases regardless of mean BP.55. Gosmanova EO, Mikkelsen MK, Molnar MZ, Lu JL, Yessayan LT, KalantarZadeh K, Kovesdy CP. Association of systolic blood pressure variability with mortality, coronary heart disease, stroke, and renal disease. J Am Coll Cardiol. 2016;68(13):1375–86. doi: 10.1016/j.jacc.2016.06.054

6. Muntner P, Shimbo D, Tonelli M, Reynolds K, Arnett DK, Oparil S. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension.2011;57(2):160-6. doi:10.1161/HYPERTENSIONAHA.110.162255
- 77. Choi S, Shin J, Choi SY, Sung KC, Ihm SH, Kim KI, Kim YM. Impact of visit-to-visit variability in systolic blood pressure on cardiovascular outcomes in Korean National Health Insurance Service-National Sample Cohort. Am J Hypertens. 2017;30(6):577–86. doi: 10.1093/ajh/hpw157. Fluctuations in physiological measures of blood pressure do not occur randomly and can contribute or be predictors of cardiovascular outcomes.

Most studies evaluated BPV on short (24h), medium (>2 days) or long-term (weekly, monthly, or annually).88. Irigoyen MC, Angelis K, Santos F, Dartora DR, Rodrigues B, Consolim-Colombo FM. Hypertension, Blood Pressure Variability, and Target Organ Lesion. Curr Hypertens Rep. 2016;18:31. doi: 10.1007/s11906-016-0642-9. , 99. Parati G, Ochoa JE, Lombardi C, Bilo G. Assessment and Management of Blood-Pressure Variability. Nat Rev Cardiol. 2013;10(3):143-55. doi: 10.1038/nrcardio.2013.1. Short-term BPV can be associated with increased cardiovascular risk.1010. Grassi G, Seravalle G, Maloberti A, Facchetti R, Cuspidi C, Bombelli M, et al. Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: findings from the BP-CARE study. J Hypertens. 2015;33(11):2250-6. doi: 10.1097/HJH.0000000000000700. , 1111. Celik M, Yuksel UC, Yildirim E, Gursoy E, Koklu M, Yasar S, et al. The Relationship between blood pressure variability and pooled cohort risk assessment equations 10-year cardiovascular risk score. Blood Press Monit. 2016;21(5):282-7. doi: 10.1097/MBP.0000000000000200.

In the study by Zarife et al.,1212. Zarife AS, Fraga-Maia H, Mill JG, Lotufo P, Griep RH, Fonseca MJM, et al. Within-visit blood pressure variability and cardiovascular risk in Elsa-Brasil Study Participants. Arq Bras Cardiol. 2022; 119(4):505-511. the authors used baseline data from 14,357 participants of ELSA-Brasil without prior history of cardiovascular disease.

BPV was quantified in a single visit at baseline by the coefficient of variation of three standardized systolic blood pressure measurements using a validated oscilometer (Omron HEM 705CPINT) and correlated with ASCVD risk. BPV was divided into quartiles, and the highest quartile was associated with a significantly higher cardiovascular risk in both men and women. Males had a higher cardiovascular risk than females in all quartiles, with the greatest difference observed in the fourth BPV quartile. In addition, comparing quartiles by sex showed a significantly higher risk for men in the third and fourth quartiles and the fourth quartile for women. BPV was also associated with higher pulse-wave velocity, lower glomerular filtration rate, and hypercholesterolemia. No studies have reported cardiovascular risk assessment and BPV in a single visit. The results from ELSA-Brasil, in this large prospective cohort suggest that this can be a marker of cardiovascular disease risk and help identify patients needing closer monitoring or more intensive therapy. It is worthy to note that the majority of participants of ELSA-Brasil were normotensive individuals (64%), reinforcing the concept that blood pressure is a continuous measure of risk and that BPV can be important not only for those with hypertension but can be assessed in subjects with normal blood pressure measures. Further steps should be assessing single visit BPV and cardiovascular outcomes in ELSA-Brasil.

Referências

  • 1
    Barroso WKS, Rodrigues CIS, Bortolotto LA, Mota-Gomes MA, Brandão AA, Feitosa ADM, et al. Diretrizes Brasileiras de Hipertensão Arterial – 2020. Arq Bras Cardiol. 2021; 116(3):516-658.doi: 10.36660/abc.20201238.
    » https://doi.org/10.36660/abc.20201238
  • 2
    Précoma DB, Oliveira GMM, Simão AF, Dutra OP, Coelho OR, Izar MCO, et al. Atualização da Diretriz de Prevenção Cardiovascular da Sociedade Brasileira de Cardiologia – 2019. Arq Bras Cardiol. 2019; 113(4):787-891. doi: 10.5935/abc.20190204.
  • 3
    Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bach M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur J Prev Cardiol.2022;29(1):5-115 doi:10.1093/eurjpc/zwab154.
  • 4
    Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension 2020;75(6):1334-57. doi: 10.1161/HYPERTENSIONAHA.120.15026.
  • 5
    Gosmanova EO, Mikkelsen MK, Molnar MZ, Lu JL, Yessayan LT, KalantarZadeh K, Kovesdy CP. Association of systolic blood pressure variability with mortality, coronary heart disease, stroke, and renal disease. J Am Coll Cardiol. 2016;68(13):1375–86. doi: 10.1016/j.jacc.2016.06.054
  • 6
    Muntner P, Shimbo D, Tonelli M, Reynolds K, Arnett DK, Oparil S. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension.2011;57(2):160-6. doi:10.1161/HYPERTENSIONAHA.110.162255
  • 7
    Choi S, Shin J, Choi SY, Sung KC, Ihm SH, Kim KI, Kim YM. Impact of visit-to-visit variability in systolic blood pressure on cardiovascular outcomes in Korean National Health Insurance Service-National Sample Cohort. Am J Hypertens. 2017;30(6):577–86. doi: 10.1093/ajh/hpw157.
  • 8
    Irigoyen MC, Angelis K, Santos F, Dartora DR, Rodrigues B, Consolim-Colombo FM. Hypertension, Blood Pressure Variability, and Target Organ Lesion. Curr Hypertens Rep. 2016;18:31. doi: 10.1007/s11906-016-0642-9.
  • 9
    Parati G, Ochoa JE, Lombardi C, Bilo G. Assessment and Management of Blood-Pressure Variability. Nat Rev Cardiol. 2013;10(3):143-55. doi: 10.1038/nrcardio.2013.1.
  • 10
    Grassi G, Seravalle G, Maloberti A, Facchetti R, Cuspidi C, Bombelli M, et al. Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: findings from the BP-CARE study. J Hypertens. 2015;33(11):2250-6. doi: 10.1097/HJH.0000000000000700.
  • 11
    Celik M, Yuksel UC, Yildirim E, Gursoy E, Koklu M, Yasar S, et al. The Relationship between blood pressure variability and pooled cohort risk assessment equations 10-year cardiovascular risk score. Blood Press Monit. 2016;21(5):282-7. doi: 10.1097/MBP.0000000000000200.
  • 12
    Zarife AS, Fraga-Maia H, Mill JG, Lotufo P, Griep RH, Fonseca MJM, et al. Within-visit blood pressure variability and cardiovascular risk in Elsa-Brasil Study Participants. Arq Bras Cardiol. 2022; 119(4):505-511.
  • Short Editorial related to the article: Within-Visit Blood Pressure Variability and Cardiovascular Risk in ELSA-Brasil Study Participants

Publication Dates

  • Publication in this collection
    21 Oct 2022
  • Date of issue
    Oct 2022
Sociedade Brasileira de Cardiologia - SBC Avenida Marechal Câmara, 160, sala: 330, Centro, CEP: 20020-907, (21) 3478-2700 - Rio de Janeiro - RJ - Brazil, Fax: +55 21 3478-2770 - São Paulo - SP - Brazil
E-mail: revista@cardiol.br